Header Logo

The impact of AD drug treatments on event-related potentials as markers of disease conversion.

Chapman RM, Porsteinsson AP, Gardner MN, Mapstone M, McCrary JW, Sandoval TC, Guillily MD, Reilly LA, DeGrush E. The impact of AD drug treatments on event-related potentials as markers of disease conversion. Curr Alzheimer Res. 2013 Sep; 10(7):732-41.

View in: PubMed